Updates are available Correction dated 2023-08-05
Click to view Correction: https://doi.org/10.1007/s40262-023-01290-y
-
Authors
Zannikos, Peter http://orcid.org/0000-0001-9444-3862
Solanki, Bhavna
De Meulder, Marc
Badorrek, Philipp
Hohlfeld, Jens M. http://orcid.org/0000-0003-2646-6186
Singh, Jaskaran
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct02154334 at ClinicalTrials.govDocuments that mention this clinical trial
Pharmacokinetics of Nasal Esketamine in Patients with Allergic Rhinitis with and Without Nasal Decongestant Pretreatment and in Healthy Subjects with and Without Nasal Corticosteroid Pretreatment
https://doi.org/10.1007/s40262-023-01273-z
- License Information
-
More Information
Article History
Accepted: 1 June 2023
First Online: 4 July 2023
Change Date: 5 August 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s40262-023-01290-y
Declarations
:
: The clinical study and the analyses presented were supported by research funding from Janssen Research and Development, LLC.
: Peter Zannikos, Bhavna Solanki, Marc De Meulder, and Jaskaran Singh were employed by Janssen Research & Development, LLC at the time the study was conducted and, as such, may have been eligible for stock and stock options.
: The datasets generated and/or analyzed during the study belong to Janssen Research & Development, LLC and are not publicly available.
: The protocol was approved by an Institutional Review Board (Medizinische Hochshule Hannover Carl-Neuberg-Strasse 1, 30625 Hannover, Germany). The study was conducted at a single center (Fraunhofer Institute for Toxicology and Experimental Medicine, Hannover, Germany) in accordance with the ethical principles that have their origin in the Declaration of Helsinki and that are consistent with Good Clinical Practices and applicable regulatory requirements. The study was registered in the Clinical Trials (NCT02154334) and EudraCT (2014‐000534‐38) registries.
: Written informed consent was obtained from each participant before enrollment in the study after being advised of the potential risks and benefits of the study, as well as the investigational nature of the study.
: All authors provided final approval of the published version.
: Not applicable.
: All authors participated in the study design and implementation and/or conduct of the study. All authors read and approved the final manuscript.
